A day dedicated to bringing science closer to young people and promoting Alzheimer’s research.
El passat divendres, Ace Alzheimer Center Barcelona va rebre la visita d’un grup d’alumnes de St Peter’s School, en el marc de la seva col·laboració amb el projecte Jeans4Genes, impulsat per Genes4All. La jornada va oferir als estudiants una oportunitat única per conèixer de prop com es treballa en un centre especialitzat en el diagnòstic, la recerca i el desenvolupament de noves eines per comprendre millor les malalties neurodegeneratives.
Students were able to explore the daily work of our research and development units, where they learned how data are generated and analyzed, which technologies are used, and the scientific challenges currently faced by the research community in the field of Alzheimer’s disease.
A donation that boosts research
As part of this collaboration, students from St Peter’s School organized a fundraising initiative through which they raised €2,000. This contribution, which they have decided to allocate entirely to the research carried out at Ace Alzheimer Center Barcelona, will help support projects focused on understanding the genetic basis of the disease and identifying biomarkers that enable earlier and more accurate diagnosis.
This initiative highlights the commitment of younger generations to science and health and underscores the importance of building bridges between educational institutions and research centers.
Miren Jone Gurrutxaga, directora d’Ace Alzheimer Center Barcelona afirma: “Valorem molt positivament aquesta experiència, que contribueix a despertar vocacions científiques i a sensibilitzar els joves sobre l’impacte social de les malalties neurodegeneratives. Iniciatives com aquesta reforcen el nostre compromís amb la divulgació i amb la construcció d’una comunitat més informada i implicada en la recerca biomèdica.”
Bringing science closer to young people: a commitment to the future
The visit allowed students to learn first-hand about the fundamental role of research in the fight against Alzheimer’s disease, as well as the importance of collaboration among institutions to move toward a future with better diagnostic and therapeutic options.
